Aberrant expression of ZEB1 in endometrial cancers, gastric cancer and hepatocellular carcinoma has been associated with aggressive disease, poor differentiation, development of metastases and poor clinical prognosis (19–21). The gene discussed is ZEB1; the disease is hepatocellular carcinoma.